Apoptosis with FasL + cell infiltration in the periphery and thymus of corrected autoimmune mice
Open Access
- 30 October 1997
- journal article
- research article
- Published by Wiley in Immunology
- Vol. 92 (2) , 206-213
- https://doi.org/10.1046/j.1365-2567.1997.00347.x
Abstract
Fas (CD95) ligand (L) is a death factor that binds to its receptor, Fas, and induces apoptotic cell death, a crucial process in immunological tolerance. gld (generalized lymphoproliferative disorder) mice, which have a point mutation in the FasL gene, develop spontaneous systemic autoimmune syndromes characterized by hypergammaglobulinaemia and lymphoid hyperplasia owing to accumulation of abnormal B220+ CD3+ cells. Transplantation of wild‐type (wt) bone marrow cells into old gld mice on the same strain background results in normalization of autoimmune syndromes. We characterized the cellular mechanisms (functionally and histologically) of the above phenomena in gld mice after bone marrow transplantation (BMT) to determine the role of apoptosis via Fas/FasL interactions in inducing and maintaining self‐tolerance in vivo. Activated splenocytes from wt and BMT (wt to gld ) mice showed significant cytotoxic activity against Fas‐transfectant cells while those from BMT ( gld to gld ) mice did not. Cells in the thymus, spleen and lymph nodes of gld mice uniformly upregulated Fas expression and were sensitive to Fas‐mediated apoptosis compared with those in wt mice. Cells sensitive to Fas‐mediated apoptosis in gld mice resided not only among abnormal B220+ CD3+ cells but also among conventional lymphocytes. More importantly, histological analysis revealed that cells in the spleen, lymph nodes and thymus frequently underwent apoptosis with infiltration of FasL+ cells in BMT (wt to gld ) mice compared with BMT ( gld to gld ) mice. Our results indicated that apoptosis via Fas/FasL interactions can directly eliminate pathogenic cells responsible for autoimmunity in the periphery and possibly in the thymus in vivo.Keywords
This publication has 28 references indexed in Scilit:
- Selective apoptosis of CD4+CD8+ thymocytes by the anti-Fas antibody.The Journal of Experimental Medicine, 1995
- In vivo depletion of Thy-1-positive cells originating from normal bone marrow abrogates the suppression of gld disease in normal-gld mixed bone marrow chimeras.The Journal of Immunology, 1995
- Co-infusion of normal bone marrow partially corrects the gld T-cell defect. Evidence for an intrinsic and extrinsic role for Fas ligand.The Journal of Immunology, 1995
- Massive upregulation of the Fas ligand in lpr and gld mice: implications for Fas regulation and the graft-versus-host disease-like wasting syndrome.The Journal of Experimental Medicine, 1995
- Cytotoxicity of fresh NK1.1+ T cell receptor alpha/beta+ thymocytes against a CD4+8+ thymocyte population associated with intact Fas antigen expression on the target.The Journal of Experimental Medicine, 1994
- Generalized lymphoproliferative disease in mice, caused by a point mutation in the fas ligandCell, 1994
- Chronic treatment of C3H-lpr/lpr and C3H-gld/gld mice with anti-CD8 monoclonal antibody prevents the accumulation of double negative T cells but not autoantibody production.The Journal of Immunology, 1994
- Molecular cloning and expression of the fas ligand, a novel member of the tumor necrosis factor familyCell, 1993
- Origin of CD4-CD8-B220+ T cells in MRL-lpr/lpr mice. Clues from a T cell receptor beta transgenic mouse.The Journal of Immunology, 1993
- Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.The Journal of cell biology, 1992